NeoStem, Inc., which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, announced today it has signed a license agreement to obtain the exclusive worldwide rights to innovative stem cell technology and applications for cosmetic facial and body procedures and skin rejuvenation.
The licensed technology, which includes an issued as well as pending patent application, was developed by Vincent C. Giampapa, M.D., F.A.C.S., a Board-certified plastic reconstructive surgeon and Assistant Clinical Professor of Plastic and Reconstructive Surgery at the University of Medicine and Dentistry of New Jersey. Dr. Giampapa, one of the first certified anti-aging medical physicians in the world, is Director of the Plastic Surgery Center Internationale and The Giampapa Institute for Anti-Aging Medical Therapy.
“We are extremely pleased to sign this agreement with Dr. Giampapa,” said Robin Smith, MD, CEO of NeoStem, “Acquisition of the exclusive worldwide rights to these innovative stem cell skin rejuvenation procedures enhances NeoStem’s leadership in the anti-aging and regenerative medicine arena. This has long been one of our core pursuits. Our earliest stem cell collection center is focused on treatments for physical aging. Recently, we agreed to acquire through a series of contractual arrangements, control over Shandong New Medicine Research Institute of Integrated Traditional and Western Medicine Limited Liability Company, a China limited liability company. Shandong is a leader in integrated traditional and western medicine in the People’s Republic of China, and provides a multitude of treatments including cell regenerative therapies.”
In January 2009, Dr. Giampapa presented and demonstrated some of his skin rejuvenation techniques using autologous adult stem cells at the 2009 International Stem Cell Technology and Applications Summit in Qingdao, China. His demonstrations were televised by China Central Television (CCTV), attracting wide public interest as well as professional interest from the Summit’s audience of leading stem cell practitioners.
Dr Smith noted, “The excitement these new treatments are generating in China open strong new potential for NeoStem in the field of age management. Just as we envision Shandong as creating a destination treatment site for people seeking new clinical advances not yet available in their own home countries, we believe our ability to make widely available our new proprietary regenerative therapies in the United States will attract many people from China and around the world seeking safe and effective treatment here.
About NeoStem, Inc.
NeoStem is developing a network of adult stem cell collection centers that are focused on enabling people to donate and store their own (autologous) stem cells when they are young and healthy for their personal use in times for future medical need. The Company has also recently entered into research and development through the acquisition of a worldwide exclusive license to technology to identify and isolate VSELs (very small embryonic-like stem cells), which have been shown to have several physical characteristics that are generally found in embryonic stem cells.
For more information, please visit: www.neostem.com.
Dr Giampapa has recently been added to the Medical Advisory Board of new US based company Jeunesse Global Please see this report from Jeunesse Global Leader in Sales, Wendy d'Entremont
Double "WOW!!" on the Jeunesse Global first official conference and launch into the U.S. markets! This company knows how to treat its distributors royally. I was picked up at the airport by the company upon arrival and driven to the beautiful resort where the event was held. We had a spectacular "meet and greet" buffet on Friday evening, followed by a day and a half of opportunity and information sessions, and then a scrumptious banquet and dance, followed by our team getting together for laughs and fun. On Sunday morning, the COO's Executive Assistant drove me back to the airport for my international flight.
I had an opportunity to spend business and fun time with team members and had a fantastic opportunity to meet people who had been with the company for a year or more. Approximately 70% of the conference attendees were from the Asian markets where the product was launched about 18 months ago to rave reviews. I saw some phenomenal results from people who had been using the stem cell technology skincare on their faces and hands for several months. VERY impressive!
From a business standpoint, one speaker described Jeunesse powerfully and succinctly
(a) Latest, ahead-of-the-trends adult stem cell technology
(b) "New" company (although 18 months old in the U.S., marketing efforts were focused in Asia) so only 6,000 distributors, approximately, in the U.S. (or, on average, 120 per state) "New yet stable" is, in my opinion, a networker's dream and VERY difficult to find in this industry.
(c) Global platform (shipping into 70 countries, with offices in several, registered NFR in many including Canada)
Two exciting announcements were made during the weekend
First, Wendy Lewis very excitedly announced to us that Jeunesse is officially a member of the D.S.A. after being a "pending member" for a year. She said that it was a long-time goal for her company to be a member and her excitement and emotion were clear.
And secondly, along with cosmetic surgeon – dermatologist, Dr. Nathan Newman, who formulated the product as a result of successfully performing stem cell facelifts, Jeunesse has a new member of the Medical Advisory Board who spoke in depth to us about stem cell technology. His endorsement of this company and product is very exciting and I'm thrilled to share his bio with you:
Dr. Vincent C. Giampapa is a Board Certified Plastic Reconstructive Surgeon and Assistant Clinical Professor of Plastic and Reconstructive Surgery at the University of Medicine and Dentistry of New Jersey. He is the Director of the Plastic Surgery Center Internationalé and The Giampapa Institute for Anti-Aging Medical Therapy.
Dr. Giampapa received his M.D. degree from Mt. Sinai Medical School in New York City, New York and continued his medical training in aesthetic plastic surgery. Upon becoming a certified plastic surgeon, Dr. Giampapa completed a year of microsurgery and hand fellowship at New York University Medical Center. He is a Fellow of the American College of Surgeons, a Founding Member of the American Academy of Anti-Aging Medicine and served as President of the American Board of Anti-Aging Medicine. He was one of the first Board Certified anti-aging aesthetic plastic surgeons in the world.
Over the past seven years, Dr. Giampapa has been featured in many radio and television programs, including Phil Donahue, Joan Rivers, Geraldo Rivers and the McLaughlin Report. He has also published numerous articles in both national and international plastic surgical journals as well as book chapters. He has been features in many articles in both national and international magazines concerning cosmetic surgery and new surgical techniques.
Dr. Giampapa has served as Research Fellow for such other prestigious institutes as Columbia Presbyterian Medical Center in New York City and has been the Director of Microsurgery and Re-plantation Surgery at the University of Medicine and Dentistry of New Jersey. His writings have been published in numerous academic journals including the Annals of Plastic Surgery, the Journal of Plastic Reconstructive Surgery as well as the Journal of Reconstructive Microsurgery.
He has also served as a consultant for NASA in reference to the robotic arm of the space shuttle. His research has been published in technical journal formats as well as genetic engineering journals and other research publications.
He has been awarded over a dozen patents from the United States Government for unique cell culture delivery techniques as well as new drug delivery systems, and surgical instrument designs.
Dr. Giampapa is well known in the United States, Latin America and Europe where he lectures regularly. He is recognized as an innovator in new cosmetic and surgical techniques and surgical instrumentation.
http://www.youthfulneck.com/dr_giampapa.htm (not a company link, Mods)
Based on everything I saw and heard, it's my strong belief that Jeunesse is at the "tipping point" of greatness, and poised for VERY significant growth in the North American markets and around the globe. They have established offices and/or distribution centres in several Asian countries, Europe, Canada, and of course the United States, and have hired some great and experienced corporate people to help them with marketing and international expansion.
Although we've only been with Jeunesse a short time, our team is already in 3 countries and I expect to see another two countries, maybe 3, within our team over the next couple of weeks so I'm thrilled at what Shelley and I have achieved together so far, and look forward to a long, wonderful and profitable relationship with Jeunesse Global and our fantastic team!
To visit Jeunesse Global products and see their remarkable Stem Cell Serum product visit www.SmootherSkin.info
The Stem Cell Skin Care we prefer is Jeunesse.
This blog uses automatic posting software that retrieves articles of interest and posts them without being reviewed by the blog owner. If there is a problem with the content please contact shelpenney [at] yahoo.ca and we will respond as quickly as possible.